Oricula Therapeutics

About:

Oricula Therapeutics develops and commercializes drugs to prevent hearing loss.

Top Investors: University of Washington

Description:

Oricula Therapeutics develops and commercializes drugs to prevent hearing loss. The company was incorporated in 2013 and is based in Seattle, Washington.

Total Funding Amount:

$2.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wa Keeney, Kansas, United States

Founded Date:

2013-01-01

Contact Email:

gleser(AT)oricularx.com

Founders:

Graham Johnson, Vince Groppi

Number of Employees:

1-10

Last Funding Date:

2016-02-02

IPO Status:

Private

Industries: